Breast milk is superior in nutrition, It provides resistance against infections and allergies, It is naturally sterile. Despite all the advantages of breastfeeding some mothers choose to pause the breastfeeding in fear of harmful effects of medicines passing in breast milk. Are you wondering about breastfeeding and using Irbesartan Irbesartan 1.745 G ? Know what is Irbesartan Irbesartan 1.745 G and how it can affect your breast milk and whether Irbesartan Irbesartan 1.745 G is safe for your kid or not.
What is Irbesartan Irbesartan 1.745 G used for?
Hypertension Irbesartan tablet USP is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. Nephropathy in Type 2 Diabetic Patients Irbesartan tablet USP is indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. In this population, irbesartan tablet USP reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end-stage renal disease (need for dialysis or renal transplantation) (see CLINICAL PHARMACOLOGY : Clinical Studies ).
I am breastfeeding mother and I am using Irbesartan Irbesartan 1.745 G. Can it have any bad effect on my kid? Shall I search for better alternative?
As Irbesartan Irbesartan 1.745 G is made of only Irbesartan, and Irbesartan is unsafe to use in breastfeeding we can safely reach on conclusion that Irbesartan Irbesartan 1.745 G is also unsafe to use while breastfeeding. Below is detailed analysis of Irbesartan and Irbesartan Irbesartan 1.745 G during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.
Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers It is not known whether irbesartan is excreted in human milk, but irbesartan or some metabolite of irbesartan is secreted at low concentration in the milk of lactating rats. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Irbesartan Irbesartan 1.745 G Breastfeeding Analsys
Irbesartan while Breastfeeding Unsafe
CAS Number: 138402-11-6
At latest update, relevant published data on excretion into breast milk were not found. Because of a high protein-binding capacity, a significant excretion into breast milk is unlikely. However, it is one among the Sartan drugs (ARA-II type) with the longest half-life and highest oral bioavailability. The latter properties make it less convenient for use while breastfeeding. Reportedly, a newborn infant appeared with transient renal failure (kidney malfunction) whose mother had taken this medication during pregnancy. Until more data on this medication is available safer alternative drugs are preferred especially in premature babies or during the neonatal period. Should an ARA-II medication (Sartan type) be necessary, the associated risk may be decreased by choosing the one with a favorable pharmacokinetics (shorter half-life elimination time and lower bioavailability) like Eprosartan and Losartan.
Irbesartan Irbesartan 1.745 G Breastfeeding Analsys - 2
Irbesartan while Breastfeeding
CAS Number: 138402-11-6
Because no information is available on the use of irbesartan during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
What if I already have used Irbesartan Irbesartan 1.745 G?
We have already established that Irbesartan Irbesartan 1.745 G is unsafe in breastfeeding and breastfeeding while using Irbesartan Irbesartan 1.745 G is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.
I am nursing mother and my doctor has suggested me to use Irbesartan Irbesartan 1.745 G, is it safe?
If your doctor knows that you are breastfeeding mother and still prescribes Irbesartan Irbesartan 1.745 G then there must be good reason for that as Irbesartan Irbesartan 1.745 G is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.
If I am using Irbesartan Irbesartan 1.745 G, will my baby need extra monitoring?
Yes, Extra monitoring is required if mother is using Irbesartan Irbesartan 1.745 G and breastfeeding as it is considered unsafe for baby.
Who can I talk to if I have questions about usage of Irbesartan Irbesartan 1.745 G in breastfeeding?
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week